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Abstract
Genetic variation in serotonin transporter (SERT) that reduces transcriptional efﬁciency is associated with higher anxiety
and fear traits and a greater incidence of post traumatic stress disorder (PTSD). Although previous studies have shown
that rats with no expression of SERT (SERT−/−) have increased baseline anxiety behaviors, SERT+/− rats with low SERT
expression (and more relevant to the clinical condition with low SERT expression) do not. Yet, no systematic studies of
fear acquisition/extinction or their underlying neural mechanisms have been conducted in this preclinical genetic
SERT+/− model. Here we sought to determine if SERT+/− or SERT−/−, compared to wildtype, rats would show
exacerbated panic responses and/or persistent conditioned fear responses that may be associated with PTSD or
phobia vulnerability. Results: Only SERT−/− rats showed increased baseline anxiety-like behaviors with heightened
panic respiratory responses. However SERT+/− (also SERT-/-) rats showed enhanced acquisition of fear and delayed
extinction of fear that was associated with changes in serotonergic-related genes (e.g., reduced 5-HT1A receptor) and
disrupted inhibition within the basolateral amygdala (BLA). Furthermore, the disrupted fear responses in SERT+/− rats
were normalized with 5HT1A antagonist infusions into the BLA. Enhanced acquisition and failure to extinguish fear
memories displayed by both SERT−/− and SERT+/− rats are cardinal symptoms of disabling anxiety disorders such as
phobias and PTSD. The data here support the hypothesis that reduced SERT function is a genetic risk that disrupts
select gene expression and network properties in the amygdala that could result in vulnerability to these syndromes.
Introduction
Post traumatic stress disorder (PTSD) and panic dis-
order (PD) represent some of the most severe and dis-
abling trauma/anxiety related disorders1. Severe and or
repeated psychological trauma can result in PTSD,
which is associated with symptoms such as persistent
fear associated memories (e.g., ﬂashbacks) that can
trigger panic attacks (PA)2 and lead to avoidance of
activities, places and stimuli that produce these ﬂash-
backs. In regards to PD, the cardinal symptoms are
unexpected and recurrent (uPA)’s that occur in the
absence of a clear external trigger and are estimated to
account for ~40% of PA’s3. Recurrent unexpected PAs
can produce a conditioned avoidance response that
occurs when people with PD are traumatized by the
uPA’s and begin to fear situations that are associated
with the uPA’s. This can then induce expected PA’s3 and
agoraphobia in ~50% of humans with PD4. Although
unexpected, PA’s can be reliably induced in humans
with PD with viscerosensory associated stimuli such as
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5–7% hypercapnic gas exposure5–7, which do not induce
PAs in healthy controls at these concentrations. The
relevance is that subtle increases in CO2 in the blood
caused by hypoventilation or holding one’s breath result
in acidosis in peripheral and central brain structures
that initially results in an increase in respiration activity
to help “blow off” excess CO2 [see review
8]. However, a
sense of suffocation occurs if CO2 levels continue to
increase, which also produces adaptive behavioral and
autonomic responses that recapitulate symptoms of
PA’s. For example, higher concentrations of 20% CO2
will induce symptoms consistent with PA’s in healthy
humans9 and also induce concentration dependent
increases in fear in healthy humans that is greater (more
severe) in humans with PD10. Thus there is evidence
that the initial PD pathology is associated with an
alteration in central neural pathways which renders
them susceptible to uPA’s when exposed to otherwise
non panic inducing viscerosensory stimuli11.
In the US, there is evidence that the risk of being
exposed to a severe trauma could be as high as 75%12, yet
PTSD occurs in only about 7% of the population13 [see
also review14]. Therefore the risk of being traumatized is
much higher than the prevalence of PTSD. This suggests
that the majority of people have some resiliency to trau-
matic events, but others may be more vulnerable (e.g.,
genetic contributions). In regards to PD, the prevalence in
the general population is ~2–5%4,15 with a strong herit-
ability in ﬁrst degree relatives (~11%) and monozygotic
twins (30–40%)16,17, suggesting that in this case there are
clear genetic contributions. Consistent with this hypoth-
esis is that in humans with PD a meta-analysis of candi-
date genes identiﬁed several replicable candidate genes18
such as serotonin transporter (SERT) polymorphisms
which is associated with severity of PAs18,19. SERT reup-
take inhibitors (SSRIs) are also the gold standard for
treating severe anxiety/trauma disorder such as PD and
PTSD20,21. In 1996 Lesch and colleagues assessed anxiety
traits in humans carrying a speciﬁc polymorphism in the
promoter region of the SERT gene, where the dominant
short (s) allelic variant reduces transcriptional efﬁciency
of the SERT22, which is evidenced by reduced brain SERT
mRNA levels23, and reduced binding24. It has been
determined that humans with this SERT polymorphism
have increased anxiety-associated traits22 and enhanced
fear conditioned responses25,26. This speciﬁc SERT ss-
allele polymorphism is also associated with a higher risk
of PTSD in humans exposed to high trauma27, and
although it is not associated with a higher risk for PD27 it
is associated with more severe PA’s29.
Among anxiety circuits, the basolateral amygdala (BLA)
is a critical site where serotonin plays an important role in
modulating anxiety and fear responses and is highly
responsive to stressful stimuli30–34. The BLA also plays a
critical role in fear conditioned responses [see
reviews35,36]. Humans with the SERT polymorphism have
enhanced baseline amygdala activity and reactivity to
fearful stimuli that is likely a contributing factor to
increased anxiety and fear-associated traits37,38. However
humans with atrophy of the amygdala region, whom have
disrupted fear conditioned responses, display similar if not
worse panic responses to a 20%CO2 challenge
39, and in
one case study an intact amygdala was not necessary for a
subject to experience PA’s40. Consistent with this ﬁnding,
Schruers and colleagues determined that humans with the
SERT s-allele polymorphism displayed less fear to a
panicogenic CO2 challenge
41. Taken together this sug-
gests that the SERT polymorphism may not be associated
with initial unexpected PAs that are the initial phase of
PD, but may predispose them to the later development of
amygdala regulated conditioned responses such as
agoraphobia.
Similar to human SERT polymorphism, a heterozygous
null mutation of the SERT gene (SERT+/−) is also asso-
ciated with reduced transcriptional efﬁciency in rats42.
Rats with complete loss of SERT (SERT−/−) have high
baseline anxiety associated behaviors, but the SERT+/−
rats have normal anxiety behaviors, which suggests that
other risk factors such as acute or chronic stress may be
needed to observe anxiety vulnerability43,44. In light of the
SERT gene being a strong candidate gene associated with
the severity of PA’s, but not being associated with increase
panic symptoms post a CO2 challenge, we assessed
baseline anxiety; innate panic responses to a CO2 chal-
lenge (as well as cellular responses in anxiety associated
neural circuits); and fear conditioned responses in
SERT+/− and SERT−/−.
Methods and materials
Animals
SERT−/− Wistar rats were purchased from genOway
(Lyon, France) and were cross bred with wildtype
SERT+/+ Wistar rats to produce SERT+/− heterozygous
Wistar Rats42. The behavior and gene array experiments
were conducted on male 300–325 g rats, and the elec-
trophysiological experiments male 150–200 g rats. All rats
were housed individually in plastic cages under standard
environmental conditions (22 °C; 12/12 light/dark cycle;
lights on at 7:00 a.m.) for 7–10 days prior to the surgical
manipulations. Food and water were provided ad libitum.
All experiments were conducted in accordance with the
Guide for the Care and Use of Laboratory Animals, Eighth
Edition (Institute for Laboratory Animal Research, The
National Academies Press, Washington, DC, 2011) and
the guidelines of the IUPUI Institutional Animal Care and
Use Committee.
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RT-PCR to assess SERT mRNA in dorsal/median raphe
nucleus and Gene Array in BLA
Rats were rapidly anesthetized via IsoFlurane,
decapitated, and brains were removed and frozen in
isopentane chilled with dry ice, then stored at −80 °C. In
a RNase free environment, frozen brains were sliced
coronally at 300 µm (coronal) using a cryostat, and
sections were placed onto slides. The dorsal raphe
nucleus (DRn) and median raphe nucleus (MRn) were
dissected out of 3 adjacent sections and the BLA from 2
adjacent sections using a 1.0 mm Harris Micro-punch
(Electron Microscopy Sciences) and RNA processing
and RT-PCR analysis of custom TLDA were performed
as previously described45. For DRn/MRn, comparative
evaluation of quantitative real-time PCR was performed
with validated Taqman probes (Assay ID: SERT;
Rn00564737_m1 and beta actin; Rn00667869_m1,
respectively, Applied Biosystems) using the Taqman
gene expression master mix and 7900HT real-time PCR
system (Applied Biosystems). Each sample was analyzed
in triplicate, and beta actin was used as an internal
standard. The BLA tissue was processed for
serotonergic-related genes using the custom-designed
TaqMan Low Density Array (TLDA), see supplemental
table 1 for listing of genes. The gene expression
panel was normalized using geNorm approach,
which identiﬁed Gapdh, Ppia and Ppib (from the 9
endogenous control genes included in the custom
TLDA) to be used for normalization, as previously
described in ref. 45.
The light and dark box test (LDBT), open ﬁeld test (OFT),
and elevated plus maze (EPM)
Details are provided in supplemental methods. All rats
were handled 3 times a week for 3–5min by experimenter
prior to the day of behavioral assays. Brieﬂy, the LDBT
apparatus consisted of one lit compartment (50 lux) and
one dark compartment, which were adjacent to each other
with a small opening enabling the rat to transition
between the boxes during 5min test. The OFT arena had
4 squares forming the center; 12 squares forming the
middle perimeter; and 20 squares forming the outer
perimeter. On the test day, rats were placed in the
center and the time spent in the different zones during
the 5 min test. Both tests were video-recorded and
scored using Anymaze video tracking software (Stoelting,
Woods Dale, IL).
The elevated plus maze consisted of 2 long arms with no
walls, an intersection, and 2 closed walls. On the test day,
the animals were placed in the center area of the maze
and allowed to explore the open and closed arms for
5 min. The total amount of time spent in each arm was
recorded directly to the computer from the infrared beam
breaks.
Gas infusion procedure for in vivo respiration activity
measures
All rats were handled 3 times a week for 3–5min by
experimenter prior to the day of gas infusions. Rats were
placed in a clear Plexiglass® cylindrical plethysmograph
chamber with atmospheric air infused at a ﬂow rate of
2.8 l/min using a Vetamac ﬂowmeter (Rossville, IN) until
a steady baseline respiration rate was noted. All rats had
infusions of the following: (1) 5 min infusion of atmo-
spheric gas (<1% CO2, 21% O2, 79% N2) for baseline
measurements, then (2) either the control gas or experi-
mental normoxic, hypercarbic gas (7.5% CO2, 21% O2,
59% N2) for 5 min, and ﬁnally, (3) 5 min infusion of
atmospheric gas. A pressure ampliﬁer (model
24PC01SMT, Honeywell Sensor, Golden Valley, MN) was
connected to a Powerlab data 8/35 acquisition system
(ADInstruments, Colorado Springs, CO) and respiration
rate was assessed by calculated using LabChart software
(ADInstruments), and sighing was also visualized using
Labchart software. A sigh was deﬁned as an initial
respiration that immediately precedes an additional sec-
ond deeper inspiration. The sigh is followed by an
expiration that is larger than usual, and is often accom-
panied by a post sigh apnea46. Supplemental Fig. 1 illus-
trates the changes in the concentrations of CO2 and O2
that occur prior to, during and at offset of gas infusion.
Ninety min following the initiation of treatment, rats
were anesthetized with an overdose of isoﬂurane then
perfused transcardially with 0.05M phosphate buffered
saline (PBS; 250 ml), followed by PBS containing 4%
paraformaldehyde (PFA) and 3% sucrose and the brains
were removed and processed for immunohistochemistry
as described in detail previously47.
Immunohistochemistry procedures for c-Fos and SERT
Free-ﬂoating sections were washed in 0.05M PBS for
10min × 3 between initial incubation in 1% H2O2 in PBS
for 20 min. Immunostaining for SERT protein and c-Fos
protein was accomplished with sequential immunohisto-
chemical procedures using (1) primary antibodies directed
against SERT (rabbit anti-SERT polyclonal antibody, Cat.
no. 24330, Immunostar, diluted 1,1000) and c-Fos (rabbit
anti-c-Fos polyclonal antibody, Cat. no. sc-52, Ab-5, Santa
Cruz Biotech., Santa Cruz, CA, USA; diluted 1:10,000)
which were incubated on orbital shaker 12–14 h then
washed in PBS prior to and in between 2 h incubations in:
(1) biotinylated secondary antibodies; (2) avidin biotin
complex kit; and (3) chromogen kit as described
previously47.
Densitometry of SERT-ir in dorsal raphe nucleus (DRn) and
Counting of c-Fos-ir cells
Selection of anatomical levels for analysis of SERT
immunostaining in the DRn and c-Fos-immunostaining
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in anxiety circuits was conducted with reference to illus-
trations from a rat brain stereotaxic atlas48. Photo-
micrographs of the SERT immunostaining in the DRn
were taken at ×400 magniﬁcation using a DMLB
Leica binocular brightﬁeld microscope at 3 Bregma levels
[i.e., −7.4, −7.5, −7.6 mm from Bregma] for each rat.
Densitometry analyses were done on grayscale inverted
photographs using Adobe Photoshop version 16 for each
Bregma level for each rat and combined prior to analyses.
The WT mean represented 100% which was compared to
SERT+/− and SERT−/− values.
The numbers of c-Fos-ir cells were counted in the entire
ﬁeld of view at ×400 magniﬁcation in brain regions
implicated in innate panic responses [i.e., the dorsomedial
hypothalamic nucleus (DMN) at −2.80 mm Bregma and
dorsolateral periaqueductal gray (DLPAG) at −8.00 mm
Bregma] and conditioned fear responses [i.e., central
amygdaloid nucleus (CeA); basolateral amygdaloid
nucleus (BLA), basolateral amygdaloid nucleus, ventral
part (BLV); lateral amygdaloid nucleus (LA); and medial
amygdaloid nucleus (MeA) at −2.80 mm Bregma]. All cell
counts were done by an observer that was blind to the
experimental treatment of each animal.
Photography
Photomicrographs were obtained the Leica DMLB
microscope connected to a Leica DFC 300 digital camera
and Leica Applications Suite 4.1 for Windows.
Fear conditioning protocol
All rats were handled 3 times a week for 3–5min by
experimenter prior to the day of behavioral assays. The
fear-conditioning chamber has a grid ﬂoor composed of
6 stainless steel rods connect to a shock generator (Kinder
Scientiﬁc, Poway, CA, USA). The fear conditioning pro-
tocol was 4 days long. On day 1, rats were placed in the
conditioning chamber and allowed to habituate for
10min. On day 2, test day 1, the rats were placed back in
the conditioning chamber and was exposed to 5 tone+
shock pairings, with a 120 s inter-trial interval with a tone
conditioned stimuli (CS: 80 dB, 20 s) co-terminating with
a single shock unconditioned stimuli (UC: 0.80 mA,
500ms). On day 4, test day 2, rats underwent an extinc-
tion paradigm where they were presented with 20 tone CS
only with a 120 s inter-trial interval. All sessions were
video-recorded and the total time spent freezing during
the tones on all 2 test days was scored blind by the
investigator Stephanie Fitz.
Injections of 5-HT1A receptor agonist into BLA prior to fear
acquisition and extinction of SERT+/− rats
All rats were handled 3 times a week for 3–5min by
experimenter prior to the day of behavioral assays.
SERT+/− rats (n= 9) were anaesthetized by placing them
in a closed Plexiglas® box that was connected to an iso-
ﬂurane system (MGX Research Machine; Vetamic, Ross-
ville IN, USA) and then with a nose cone connected to the
same system during the stereotaxic surgery. Rats were
placed into an ultra-precise stereotaxic instrument (Kopf
Instruments, Tujunga, CA, USA) with the incisor bar set
at –3.3 mm and nose cone connected to the same system
during the surgery. Two stainless steel guide cannulae (26
gauge, Plastics One, Roanoke, VA) were situated into
guide cannulae holders ﬁxed onto the stereotaxic arms.
The 33 gauge injector was lowered into position of the
BLA using coordinates (anterior, –2.1 mm; lateral,
±5.0 mm; ventral, –8.5 mm) according to a standard ste-
reotaxic atlas of the adult rat brain48. The guide cannulae
were secured into place using three 2.4 mm screws
anchored into the skull along with cranioplastic cement.
Following placement of dummy cannulae into the guide
cannulae, rats were removed from the stereotaxic appa-
ratus and allowed to recover for 72 h prior to experi-
mental testing. SERT+/− rats received bilateral 200 nL
injections of either artiﬁcial cerebrospinal ﬂuid (aCSF,
n= 5) or 20mM 8-Hydroxy-2-(dipropylamino)tetralin
hydrobromide (8-OH-DPAT, a 5-HT1A agonist, Sigma,
n= 4) 20min prior to acquisition and recall/extinction at
a rate of 100 nL/min using 10-μl Hamilton syringes
attached to an infusion pump (Harvard Apparatus, model
PHD 2000) and subsequently connected to the injection
cannulae via polyethylene (PE 50) tubing (Fisher Scien-
tiﬁc, Pittsburg, PA). Once the injection cannulae were
securely placed into the rat, the infusion pump was turned
on and set to automatically deliver 100 nL/site over 2 min.
Following the injection, the cannulae remained in place
for an additional min before being removed. Smooth ﬂow
of the solutions via the tip of the injection cannulae was
veriﬁed before and after each injection to ensure proper
drug delivery.
Electrophysiology
Once anesthetized, brains were quickly dissected, and
350-μm coronal slices were obtained as described ear-
lier49. Brieﬂy, slices were incubated in an oxygenated (95%
O2/5% CO2 mixture) artiﬁcial cerebrospinal ﬂuid (ACSF)
of the following composition (in mM): 130 NaCl, 3.5 KCl,
1.1 KH2PO4, 1.3 MgCl2, 2.5 CaCl2, 10 glucose, 30
NaHCO3 at room temperature for ~1 h before the
recording. Slices containing the BLA were then trans-
ferred to a recording chamber mounted on the stage of
the upright Nikon E600FN microscope (Nikon Instru-
ments Inc., Melville, NY) and perfused at rate of 2–3ml/
min with ACSF heated to 30 °C. Whole-cell patch clamp
recordings were obtained using standard techniques with
borosilicate glass electrodes (resistance 3–5MΩ, WPI,
Sarasota, FL) ﬁlled with a potassium gluconate-based
solution of the subsequent composition (in mM): 140
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potassium gluconate, 2 KCl, 3 MgCl2, 10 HEPES, 5
phosphocreatine, 2 potassium-ATP, 0.2 sodium-GTP)
adjusted to pH 7.3 with KOH, and having an osmolarity of
285–295 mOsm. Whole-cell access resistance varied
between 5 to 20MΩ and was examined during each
experiment; a change of less than 15% was acceptable.
The data were obtained only from pyramidal neurons
located in BLA. Whole-cell recordings were made with a
Multiclamp 700B ampliﬁer (Molecular Devices, Sunny-
vale, CA) using the pClamp 10.3 software and a Digidata
1322 A interface (Molecular Devices, Sunnyvale, CA).
Statistical analyses
The following dependent variables were analyzed using
an ANOVA with genotype as the main independent
variable (i.e., light dark box test, open ﬁeld and elevated
plus maze, sighs, c-Fos-ir cells, SERT-ir densitometry, and
electrophysiology data). Respiratory responses over time
and fear conditioned freezing behavior was analyzed using
a one way ANOVA with repeated measures with genotype
as independent variable and time as the repeated mea-
sures. In the presence of signiﬁcant effects, between and
within subjects post-hoc tests were conducted using a
Fisher’s LSD or Dunnett’s post-hoc test, respectively.
Statistical signiﬁcance was accepted with p ≤ 0.05. All
statistical analyses were done with SPSS 25 and Graphpad
Prizm 7.0; and all graphs were generated using Graphpad
Prizm 7.0 for Windows. Figureplates were made with
CorelDraw X for Windows.
Results
Genotyping and SERT mRNA expression in DRn/MRn and
SERT immunohistochemistry in the DRn
In order to verify the diminished SERT transcriptional
efﬁciency of SERT+/− and SERT−/− rats, we measured
SERT mRNA in micropunched tissue containing the
DRn/MRn region, which revealed that, compared to
wildtype SERT+/+ controls (n= 3), SERT−/+ rats (n= 5)
had approximately a 40% reduction SERT mRNA and
SERT mRNA levels were at the limit of detection for
SERT−/− rats (n= 6, F(2,11)= 83.1, p < 0.001, Fig. 1a). We
also assessed SERT protein expression with a densito-
metry analysis of SERT immunostaining in the DRn
where compared to WT rats (n= 6), SERT+/− (n= 6) and
SERT−/− (n= 6) rats had ~57% and ~88% reduction in
SERT immunostaining, respectively [F(2,15)= 11.9, p=
0.0008, Fig. 1b], which is consistent with a previous
characterization42.
Light dark box test, open-ﬁeld behavior and elevated plus
maze
Baseline assessment of innate anxiety-associated beha-
viors revealed that, compared to both wildtype SERT+/+
rats (n= 8) and SERT+/− rats (n= 13), only SERT−/− rats
(n= 11) displayed reduced time spent: (1) in the light box
(F(2,29)= 5.7, p= 0.008, Fig. 1c); (2) in the center zone of
open ﬁeld (F(2,29)= 4.0, p= 0.029, Fig. 1d); or in the open
arm+ transition zone of the elevated plus maze (F(2,29)=
4.5, p= 0.019, Fig. 1e). Compared to WT rats, SERT−/−
rats also had less transitions between light and dark box in
LDBT (F(2,29)= 6.0, p= 0.0065, data not shown) and the
number of entries into the open arm of EPM approached
signiﬁcance as being reduced (F(2,29)= 3.3, p= 0.0511,
data not shown). There was no difference in center time
entries in OFT (F(2,29)= 0.7, p= 0.515, data not shown).
Respiratory responses to atmospheric versus CO2
challenge
Assessments of respiratory activity in conscious freely
moving rats revealed that, compared to wildtype SERT+/+
(n= 6, one outlier detected with a Grubb’s test, p < 0.05)
and SERT+/− (n= 8), SERT−/− rats (n= 7) had an
increased no. of sighs (F(2,18)= 5.4, 0.014), compared to
WT rats during atmospheric control gas infusions (Fig.
2a, see also supplemental Fig. 2a,b). Although there was
no difference in sigh frequency during the CO2 challenge
(F(2,19)= 3.1, p= 0.071, Fig. 2b), in a followup experiment
there was a signiﬁcant genotype × time interaction detec-
ted on respiration rate during the CO2 challenge (F(22,308)
= 1.6, p= 0.047, Fig. 2c, see also supplemental Fig. 2c).
Speciﬁcally, posthoc analyses revealed that SERT−/− rats
(n= 11), but not SERT+/− rats (n= 13), displayed a
higher respiration rate during CO2 challenge, compared
to wildtype SERT+/+ controls (n= 7).
Cellular responses in innate panic and learned fear
network following a 7.5%CO2 challenge
Brieﬂy exposing rats to 7.5% hypercarbic gas increased
the number of c-Fos-ir cells in brain regions implicated in
innate panic responses [i.e., DMN: Kuskall Wallis
ANOVA= 5.9, p= 0.05) and also in the DLPAG: Kruskall
Wallis ANOVA= 7.7, p= 0.02) in only the SERT−/− rats
(Fig. 2d)]. Within learned fear circuits, exposing rats to
hypercarbic gas increased numbers of c-Fos-ir cells in the
LA (Kruskall–Wallis ANOVA= 8.7, p= 0.01) of only
SERT−/− rats, but for the BLA this occurred in both
SERT+/− and SERT−/− rats (Kruskall–Wallis ANOVA=
9.5, p= 0.001, Fig. 2e).
Fear conditioning behaviors
On acquisition day all rats displayed increased freezing
over time with repeated pairings of the conditioned sti-
mulus (tone) with the unconditioned stimulus (shock).
However, a more rapid acquisition was detected in both
the SERT−/− (n= 8) and SERT+/− (n= 12) rats, com-
pared to wildtype SERT+/+ controls (n= 6, not geno-
type × tone interaction F(8,92)= 2.0, p= 0.048, Fig. 3a). On
test day 2 (evidence of consolidation), there was no
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signiﬁcant genotype × tone interaction, F(34,437)= 0.8, p=
0.80 but there was an overall genotype effect, F(2,23)= 3.6,
p= 0.044 detected. Between subjects posthoc analyses
revealed that there was no difference in recall between
groups on tone 1 with no shock. However, the SERT−/−
and SERT+/− rats showed higher freezing on subsequent
tones and had delayed extinction learning (Fig. 3b).
Intrinsic and network properties of BLA principal neurons
of SERT+/−, SERT−/−, and WT rats
We calculated number of action potentials induced by
the injected current of the same value. The BLA neurons
from SERT+/− and SERT−/− animals ﬁred signiﬁcantly
higher number of evoked action potentials compared to
the WT rats [F(2,30)= 6.04, p= 0.006, Fig. 4a, see also
supplemental Fig. 3a]. Additionally, we also observed
signiﬁcantly higher membrane input resistance between
WT (n= 12), SERT+/− (n= 11) and SERT−/− (n= 10)
groups [F(2,30)= 4.56, p= 0.02, Fig. 4b]. Last, we also
looked at BLA network properties by measuring ampli-
tude and frequency of spontaneous excitatory (EPSCs)
and inhibitory currents (IPSCs). We noticed a signiﬁcant
reduction of amplitude and frequency of spontaneous
compound IPSCs in SERT+/− and SERT−/− rats com-
pared to WT [amplitude: F(2,30)= 4.41, p= 0.021; fre-
quency: F(2,30)= 7.77, p= 0.002, Fig. 4c, see also
supplemental Fig. 3b]. No changes in amplitude and fre-
quency of sEPSCs were observed [amplitude: F(2,29)=
0.13, p= 0.883; frequency: F(2,29)= 0,11, p= 0.896,
supplemental Fig. 3b, c).
Custom serotonin-related gene TLDA
Among the twenty-one serotonin related genes (see
Suppl. Table 1) that were assessed within the BLA of WT,
Fig. 1 SERT mRNA in DRn/MRn and SERT immunohistochemistry in DRn. Bar graphs represent SERT (a) mRNA expression in the combined
dorsal/median raphe nuclei; (b) densitometry analyses of SERT immunohistochemistry in the dorsal raphe nuclei and (c–e) baseline anxiety-
associated behaviors between wildtype, SERT+/− and SERT−/− genotypes: (c) duration of time in light box, compared to dark box; (d) time spent in
center of an open ﬁeld; and (e) time spent on the combined open arm and transition zone. Bars represent mean and error bars the standard error of
the mean (SEM). Asterisks(*) indicates posthoc signiﬁcance with a Fisher’s LSD, p < 0.05
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Fig. 2 Respiratory and cellular c-Fos responses to CO2 challenge. a, b Represents bar graphs of the no. of sighs at baseline and during infusion of
7.5%CO2 (normoxic). c Line graph represents the respiratory rate responses (breaths/min) for wildtype, SERT
+/− and SER−/− rats during atmospheric
air infusions (non-shaded regions) and during hypercapnic gas (7.5% CO2, normoxic air, shaded region) infusions. Asterisks(*) indicates signiﬁcant
between subjects effects with a Fishers LSD posthoc test protected by an ANOVA, and hastag(#) indicates signiﬁcant within subject time effects with
a Dunnett’s test protected by a repeated measures one way ANOVA. d, e bar graph represents ex vivo cellular responses (evidenced by numbers of
cells with nuclear expression of c-Fos protein immunostaining) in the dorsomedial hypothalamic nucleus (DMN), dorsolateral periaqueductal gray
(DLPAG) and amygdala nuclei following exposure to 7.5%CO2 in wildtype, SERT+/− and SERT−/− rats. Error bars represent the SEM
Fig. 3 Fear conditioned behaviors. Line graph represents the mean duration of freezing of wildtype (n= 6), SERT+/− (n= 12) and SERT−/− (n= 8)
rats during a presentation of an acoustic tone on the following days: (a) acquisition of conditioning with 5 tones followed by 5 mild shocks on day 1;
(b) evidence of consolidation on day 2 with initial tone and no shock and extinction learning with subsequent tones and no shock. Asterisks(*) and
hastag(#) indicates signiﬁcant between subjects effects with a Fishers LSD posthoc test or within subject differences over time with a Dunnett’s test
(versus tone one, baseline) protected by a repeated measures one way ANOVA. Error bars represent the SEM
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SERT+/−, and SERT−/− (n= 5/ genotype) expression of
four genes, Htr2b, Htr3b, Htr5b and Slc6a4 (SERT) were
below detection limits (Ct > 34) in the BLA and were
removed from analysis. The relative expression of
remaining 17 genes had signiﬁcant resulted in signiﬁcant
main effects of Genotype, Gene and Genotype ×Gene
interaction (2way ANOVA F2,170= 4.925, P= 0.0083;
F16,170= 4.516, P < 0.0001; and F23,170= 1.641, P= 0.0241,
respectively). Seven genes were differentially express
between genotypes (Fig. 5 and Suppl. Table 1). Expression
of the 5-HT1A receptor gene (Htr1a) was signiﬁcantly
reduced compared to WT in both SERT+/− and SERT−/−
groups (Tukey’s p= 0.0099 and 0.0003, respectively).
SERT+/− and SERT−/− groups had signiﬁcantly increased
expression, compared to WT, of Htr1d (5-HT1d receptor),
Htr2c (5-HT2c receptor) and Slc18a1 (vesicular mono-
amine transporter) genes (Tukey’s p ≤ 0.022). Addition-
ally, expression of Htr4 (5-HT4 receptor) and Htr6 (5-
HT6 receptor) genes were both signiﬁcantly increased in
the SERT+/− group compared to WT (Tukey’s p= 0.0215
and 0.022, respectively).
Injections of 5-HT1A receptor agonist into BLA prior to fear
acquisition and extinction of SERT+/− rats
On acquisition day there was no difference in freezing
acquisition between SERT+/− rats with bilateral injections
Fig. 4 Intrinsic and network properties of BLA principal neurons. a bar graph summarizing the number of evoked action potentials of WT,
SERT+/− and SERT−/− rats; (b) Bar graph represents input resistance of the BLA principal neurons of wildtype (n= 12), SERT+/− (n= 11) and SERT−/−
(n= 10) rats; (d) representative spontaneous activity recordings in voltage-clamp mode from BLA neurons of WT, SERT+/− and SERT−/− rats, (e) bar
graphs summarizing amplitude and frequency of spontaneous compound IPSCs of WT, SERT+/− and SERT−/− rats; (f) bar graphs summarizing
amplitude and frequency of sEPSCs of WT, SERT+/−, and SERT−/− rats. Error bars represent the SEM
Fig. 5 Expression proﬁle of serotonin-related genes in the BLA by
genotype. Presented here are the mean (±SEM) expression, relative to
WT, of serotonin receptor genes and one vesicular monoamine
transporter 1 gene that were differentially expressed between
genotypes. Dotted red lines represent 2 fold increase or decrease in
relative expression. Asterisks(*) indicates signiﬁcantly deferent from WT
(Tukey’s p ≤ 0.022) and † indicates signiﬁcantly different from SERT+/−
(Tukey’s p= 0.0082). Error bars represent the SEM
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of artiﬁcial cerebrospinal ﬂuid vehicle (n= 5) or with 8-
OH-DPAT (n= 4) into the BLA (Fig. 6a, overall tone
effect detected F(4,28)= 46.0, p < 0.0001, but no overall
treatment effect or treatment × tone interaction F(4,28)=
0.9, p= 0.492). On test day 2, there was no signiﬁcant
treatment × tone interaction, but there was an overall
treatment effect, F(1,7)= 8,5, p= 0.022 detected. Between
subjects posthoc analyses revealed that there was no dif-
ference in recall between groups on initial tones with no
shock. However, the SERT+/− rats pretreated with 8-OH-
DPAT into the BLA displayed decreased freezing on
subsequent tones (Fig. 6b). Histology veriﬁed that all
injections were within BLA region (Fig. 6c).
Discussion
Here we ﬁrst conﬁrmed that that there was reduced
transcription of SERT mRNA and protein expression
within the DRn and MRN of SERT+/− rats and at the limit
of detection in SERT−/− rats, then also conﬁrmed that
SERT−/− rats, but not SERT+/− rats, had high baseline
anxiety associated behaviors, which are both consistent
with previous reports42–44. We then exposed SERT+/−
and SERT−/− rats to a viscerosensory challenge [i.e., 5 min
7.5% hypercapnic gas exposure] that induces PA’s in
the majority of humans with PD, but not healthy con-
trols50–52. Only SERT−/− rats showed evidence of panic
vulnerability which was evidenced by increased baseline
sighing and heightened tachypnea to the hypercapnic
challenge, which was also associated with increased cel-
lular responses in two brain regions [i.e., the DPAG and
DMH] where PA’s can be induced in human by electrical
stimulation53–55 and where panic associated behaviors
and physiological responses can be induced in rats fol-
lowing pharmacological disinhibition56–59. The hypoth-
esis that the high baseline sighing and increased
respiratory rate responses to 7.5%CO2 challenge in only
SERT−/− rats potentially indicates panic vulnerability is
consistent with clinical data. Speciﬁcally, a meta-analysis
of baseline respiratory parameters in PD determined that
PD was associated with higher baseline rate of sighing
which may a hyper responsive reaction to increases in
acidosis, a suffocation signal60. This is also consistent with
symptoms such as dyspnea, feeling out of breath, or suf-
focating during PAs, and that PA’s can be reliably induced
in humans with PD with 5-7% hypercapnic gas exposure5–
7. The lack of differences in sighing post CO2 is most
likely due to the rapid increase in respiration rate in all
rats, but that was also hyperactive in SERT−/− rats. These
SERT+/− data are also consistent with humans with the
SERT s-allele polymorphism not displaying increased
panic symptoms following a panicogenic CO2 challenge
41.
Assessment of cellular responses within the amygdala
post CO2 revealed that both SERT
-/+ and SERT−/− rats
had signiﬁcant increases within the BLA, compared to
WT rats. This was an interesting observation since pre-
vious studies have shown that even high concentrations of
20%CO2 which induces panic associated behaviors and
physiology in control rats61–63, does not increase c-Fos
Fig. 6 Fear conditioned behaviors in SERT+/- rats following 5-
HT1A receptor agonist injections in the BLA. Line graph represents
the mean duration of freezing of SERT+/− (n= 4) rats with bilateral
injections of either artiﬁcial cerebral spinal ﬂuid vehicle (n= 5) or the
5-HT1A receptor agonist 8-OH-DPAT into the BLA prior to (a)
acquisition of conditioning with 5 tones followed by 5 mild shocks on
day 1; (b) evidence of consolidation on day 2 with initial tone and no
shock and extinction learning with subsequent tones and no shock. *
and # indicates signiﬁcant between subjects effects with a Fishers LSD
posthoc test or within subject differences over time with a Dunnett’s
test (versus tone one, baseline) protected by a repeated measures one
way ANOVA. (c) Coronal illustration of a Standard stereotaxic atlas of
the rat brain with green circle and green square symbols indicating
injection cannula for SERT+/− rats injected with either vehicle or 8-OH-
DPAT, respectively. Error bars represent the SEM
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responses in the amygdala62. Because we have noted an
increase in number of c-Fos positive cells in the BLA
which plays a critical role in fear conditioned responses
[see reviews35,36], we next assessed cue induced fear
conditioned responses. Compared to WT rats, both
SERT+/− and SERT−/− rats displayed similar increases in
the acquisition of cue induced freezing and resistant fear
extinction 48 h later. These SERT+/− data are consistent
with humans with the SERT s-allele polymorphism having
enhanced fear conditioned responses25,26 and being
associated with a higher risk of PTSD in humans exposed
to high trauma27. These data suggest that although
SERT+/− rats are not vulnerable to CO2 induced panic,
they are prone to acquiring phobias which is a condi-
tioned avoidance response that occurs when people with
PD begin to fear situations/stimuli that are associated
with PA’s.
Since the SERT s-allele polymorphism is also associated
with enhanced baseline amygdala activity and reactivity to
fearful stimuli;37,38 we next assessed the basic and net-
work properties of BLA principal neurons. Here both
SERT+/− and SERT−/− rats show a reduction in the
inhibition within the BLA which was also associated with
enhanced evoked action potentials. Overall, these data
suggest that disruption of SERT transcription in both
SERT+/− and SERT−/− rats induces a prolonged presence
of serotonin in the synapses and the extrasynaptic space
which disrupts the function of the local amygdala
GABAergic network, which may also contribute in the
overall increase of the excitability of the BLA neurons.
Extracellular levels of 5-HT increase rapidly within the
BLA during fear conditioning64 and high concentrations
or prolonged application of 5-HT reduce the frequency
and amplitude of spontaneous IPSP/Cs65. Prolonged
increases in extracellular 5-HT also occur in response to
inescapable stress66, which may contribute to a net loss of
local GABA inhibition, as seen here, and subsequent
increase in excitation of glutamatergic projection neurons
following evoked responses or in response to threat. In
order to gain more insights into molecular serotonergic
network changes in the BLA of each genotype we next
assessed local expression of serotonergic associated genes.
Here we observed similar changes in gene expression in
both SERT+/− and SERT−/− rats, which correlated with
abnormalities in fear condition behaviors, but not with
baseline anxiety or panic vulnerability to CO2 challenge.
Speciﬁcally, these genotypes were associated with an
approximately 2 fold reduction in the 5-HT1A receptor
(Htr1a), and an ~ 2 fold increase in the 5-HT2C (Htr2c)
and 5HT1d (Htr1d) receptor. Within the amygdala 5-HT
receptor subtypes mediate both excitatory and inhibitory
actions on GABAergic interneurons and glutamatergic
projection neurons67. Glutamatergic neurons in the BLA
express both 5-HT1A and 5-HT2C receptors67,68, which,
respectively, are inhibitory and excitatory metabotropic
receptors. In regards to fear conditioning, 5-HT1A ago-
nist injections into the BLA region will reduce fear con-
ditioned freezing responses in rats69 and in hamsters70,
which is consistent with our data where injecting a 5-
HT1A agonist into the BLA of a SERT+/− enhanced fear
extinction. Conversely, BLA injections of a selective 5-
HT2C antagonist can attenuate fear conditioned beha-
viors71. Thus the decreased expression of the 5-HT1A
receptor and increased expression of the 5-HT2C recep-
tor could shift the effects of 5-HT release onto glutama-
tergic neurons to being more excitatory and thus enhance
fear acquisition. During fear extinction the infralimbic
region of the prefrontal cortex plays a critical role in
enhancing fear extinction partially through inhibition of
the BLA glutamatergic neurons72–75. Thus, chronic exci-
tatory effects of 5-HT onto glutamatergic BLA neurons of
SERT+/− and SERT−/− rats may interfere with inhibitory
inﬂuence to induce deﬁcits in safety learning. Overall, this
expression proﬁle could partially explain enhanced
evoked action potentials of glutamatergic neurons in the
BLA of SERT+/− and SERT−/− rats.
Conclusions
Our data are consistent with previous experiments
where depleting 5-HT levels in the BLA region diminishes
fear conditioned behaviors76. Although only the SERT−/−
rats showed a panic vulnerability to CO2, and the SERT s-
allele polymorphism is not associated with increases in
PA/PD incidence, it is interesting that reduced 5-HT1A
binding within the amygdala of humans with PD77,78
which could explain an increased incidence of expected
PAs and high phobia comorbidity and also that PAs are
more severe in PD humans with the SERT s-allele poly-
morphism29. Overall, these data are also supportive of the
hypothesis that increased 5-HT activity within the
amygdala may be contributing to the pathophysiology of
expected PA’s, phobia vulnerability and PTSD64,79.
Supplemental methods and results
RT-PCR to assess SERT mRNA in dorsal/median raphe nucleus
and gene array in BLA
Rats were rapidly anesthetized via IsoFlurane, decapi-
tated, and brains were removed and frozen in isopentane
chilled with dry ice, then stored at −80 °C. In a RNase free
environment, frozen brains were sliced coronally at
300 µm (coronal), using a cryostat, and sections were
placed onto slides. The dorsal raphe nucleus (DRn) and
median raphe nucleus (MRn) were dissected out of 3
adjacent 300 µm sections [from −7.0 to −8.0 mm (DRn)
and −7.5 to −8.5 mm from bregma using a 1.0 mm Harris
Micro-punch (Electron Microscopy Sciences) and were
placed into 75 µl of SurePrepTM TrueTotalTM RNA pur-
iﬁcation buffer/kit to isolate RNA (Fisher Scientiﬁc).
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Samples were vortexed and Total RNA was determined
using Nanodrop 1000. Extracted RNA was then reverse
transcribed using the GeneAmp Gold RNA PCR kit
(Applied Biosystems) at the following reaction conditions:
2.5 μM Oligo-dT primer, 2.5 mM magnesium, 250 mM of
each deoxynucleotide triphosphate, 0.5 U/ml of RNase
inhibitor and ﬁnal concentration of 0.75 U/μl of MuLV
reverse transcriptase. The reverse transcription conditions
were 10 min at room temp, 15 min at 42° C, 10 min at 68°
C and 5 min at 95°C and produced ~25 μl of product.
Comparative evaluation of quantitative real-time PCR was
performed with validated Taqman probes (Assay ID:
SERT; Rn00564737_m1 and beta actin; Rn00667869_m1,
respectively, Applied Biosystems) using the Taqman gene
expression master mix and 7900HT real-time PCR system
(Applied Biosystems). Each sample was analyzed in tri-
plicate, and beta actin was used as an internal standard.
The BLA region was bilaterally dissected from two
consecutive 300 µm coronal sections and tissue was pro-
cessed for serotonergic-related genes using the custom-
designed TaqMan Low Density Array (TLDA), see sup-
plemental Table 1 for listing of genes. RNA processing
and RT-PCR analysis of custom TLDA were performed as
previously described45. The gene expression panel was
normalized using geNorm approach, which identiﬁed
Gapdh, Ppia and Ppib (from the 9 endogenous control
genes included in the custom TLDA)to be used for nor-
malization, as previously described in45.
The light and dark box test (LDBT) and open ﬁeld test (OFT)
The LDBT apparatus consisted of one lit compartment
(45 × 32 × 32 cm, 50 lux; light box) and one dark com-
partment (30 × 32 × 32 cm, 5 lux), which were adjacent to
each other. A small opening (10 × 15 cm) enabled the rat
to transition between the boxes. On the test day, rats were
placed in the light compartment and the time spent in
each compartment during the 5 min test.
The OFT covered an area of 90 cm × 90 cm, with 40 cm
high walls which was divided into a 6 × 6 grid of equally-
sized squares using black tape (36 total squares) with
4 squares forming the center; 12 squares forming the
middle perimeter; and 20 squares forming the outer
perimeter. On the test day, rats were placed in the center
and the time spent in the different zones during the 5 min
test. Both tests were video-recorded and scored using
Anymaze video tracking software (Stoelting, Woods Dale,
IL).
Elevated plus maze
The elevated plus maze (Hamilton-Kinder San Diego,
CA) is 111.76 cm wide x 111.76 cm deep x 85.1 cm tall
and each arm is 10.79 cm wide and 50.16 cm long, inter-
section is 10.79 cm by 10.79 cm, closed walls are 40.00 cm
high. On the test day, the animals were placed in the
center area of the maze and allowed to explore the open
and closed arms for 5 min. The total amount of time spent
in each arm was recorded directly to the computer from
the infrared beam breaks.
Gas infusion procedure for in vivo respiration activity
measures
Rats were placed in a clear Plexiglass® cylindrical ple-
thysmograph chamber (i.d. 95 mm, length 260mm,
volume 1.84 l, wall thickness 3 mm) with atmospheric air
infused at a ﬂow rate of 2.8 l/min using a Vetamac ﬂow-
meter (Rossville, IN) until a steady baseline respiration
rate was noted. A differential pressure ampliﬁer (model
24PC01SMT, Honeywell Sensor, Golden Valley, MN) was
connected 20 cm away from the start of the output line to
a Powerlab data 8/35 acquisition system (ADInstruments,
Colorado Springs, CO) for continuous monitoring of
respiration. The second T arm connector was opened to
the room air. All rats had infusions of the following: (1)
5 min infusion of atmospheric gas (<1% CO2, 21% O2, 79%
N2) for baseline measurements, then (2) either the control
gas or experimental normoxic, hypercarbic gas (7.5% CO2,
21% O2, 59% N2) for 5 min, and ﬁnally, (3) 5 min infusion
of atmospheric gas. Respiration rate was assessed by cal-
culating the rate of pressure ﬂuctuations inside the
chamber using LabChart software (ADInstruments), and
sighing was also visualized using Labchart software. A
sigh was deﬁned as an initial respiration that immediately
precedes an additional second deeper inspiration. The
sigh is followed by an expiration that is larger than usual,
and is often accompanied by a post sigh apnea46. sup-
plemental Fig. 1 illustrates the changes in the con-
centrations of CO2 and O2 that occur prior to, during and
at offset of gas infusion.
Gas infusion procedure for in vitro measurement of ambient
CO2 and O2 concentrations
Here we used state of the art sensors (www.CO2-meter.
com, Osmond Beach, Fl) to measure changes in the
concentrations of CO2 (Cozir, GSS IR LED sensor, 0-
100% range with 3%+/− error) and O2 (UV light ﬂux
sensor, 0–25% range with 2%+/− error) within a clear
custom built Plexiglass® cylindrical plethysmograph
chamber (i.d. 95 mm, length 260mm, volume 1.84 l, wall
thickness 3 mm) with atmospheric air infused for 5 min;
then 5 min of normoxic 7.5CO2; followed by 5 min of
atmospheric air. The ﬂow rate was 2.8 l/min using a
Vetamac ﬂowmeter (Rossville, IN). The battery operated
sensors within the cages were interfaced with Gaslab data
acquisition software (www.CO2-meter.com) on a Win-
dows PC.
Initial in vitro assessments of CO2 and O2 concentration
changes following a 5min infusion of normoxic 7.5% CO2
we determined that CO2 concentrations went from
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undetectable levels to 5% within 2 min and 7–7.5%
3–6min and returned to baseline 4 min following the CO2
infusion (F(11,55)= 81.0, p < 0.001, Suppl. Fig. 1, n= 6).
Percent O2 concentrations went from 20.6%O2 to 20.9%
O2 during the CO2 challenge, then back to 20.6%O2 fol-
lowing the CO2 gas challenge (F(11,55)= 86.0, p < 0.001,
Suppl. Fig. 1, n= 6).
Supplemental Fig. 1—Line graphs in, respectively,
represent the mean ambient concentrations of CO2 and
O2 at 2 min baseline when atmospheric air was infused;
5 min post normoxic 7.5%CO2 gas infusion; and 5 min of
atmospheric air infusion. # symbol represents within
subjects over time signiﬁcance with a 2 tailed Dunnett’s
posthoc test protected by a signiﬁcant one way ANOVA
with each gas treatment as the main factor. Error bars
represent the SEM.
Supplemental Fig. 2–a-b represents representative sighs
and sigh frequency between genotypes, respectively. (c)
are representative respiratory responses to atmospheric
air in controls and to 7.5%CO2 in each genotype group.
Supplemental Fig. 3–a representative evoked action
potential recordings from BLA neurons of WT, SERT+/−
and SERT−/− rats; (c) representative spontaneous activity
recordings in voltage-clamp mode from BLA neurons of
WT, SERT+/− and SERT−/− rats, (c) bar graphs sum-
marizing amplitude and frequency of sEPSCs of WT,
SERT+/− and SERT−/− rats. Error bars represent the
SEM.
Shock sensitivity protocol
In order to conﬁrm there were no differences in shock
sensitivity between genotypes, rats from each genotype
group were placed in the same fear conditioning cham-
bers as described previously. The rats were then exposed
to a series of 500ms shocks starting at 0.1 mA and
increasing by 0.1 mA after each 20 s interval. The behavior
was recorded for the duration of the experiments and the
latency to induce a startle response was then used to
determine shock sensitivity.
In this experiment the mean shock needed to induce a
startle response was ~0.4 mA with no difference noted
between genotypes [Suppl. Fig. 4, WT, n= 6; SERT+/−
n= 5; SERT−/− n= 6; F(2,14)= 0.04, p= 0.96]. This was
also below the 0.8 mA shock used for fear conditioning
experiment.
Supplemental Fig. 4—Bar graph represents the mean
intensity of shock needed to induce a startle response
between wildtype (n= 6), SERT+/− (n= 5) and SERT−/−
(n= 5) rats. The arrow indicates the shock intensity used
for fear conditioning experiment in Fig. 3. Error bars
represent the SEM.
Supplementary Table 1—List of the 21 serotonin related
genes assessed in the BLA using a custom TaqMan RT-
PCR array microﬂuidic card.
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